Vinati Organics Ltd

Vinati Organics Ltd

₹ 1,775 0.00%
26 May - close price
About

Vinati Organics is engaged in manufacturing of speciality organic intermediates and monomers.

Key Points

Key products
IBB: #1 manufacturer with a global market share of 65% as of FY20. [1] IBB is the raw material for ibuprofen and Vinati is one of the largest global producer of IBB. The current installed capacity is 25,000 MTPA. [2]

  • Market Cap 18,241 Cr.
  • Current Price 1,775
  • High / Low 2,377 / 1,693
  • Stock P/E 39.8
  • Book Value 216
  • Dividend Yield 0.37 %
  • ROCE 30.3 %
  • ROE 22.6 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 8.22 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
245 232 219 223 280 386 374 369 486 506 566 509 503
144 134 135 151 181 285 273 276 347 375 418 345 351
Operating Profit 102 97 84 72 99 102 101 93 139 131 148 164 152
OPM % 41% 42% 38% 32% 35% 26% 27% 25% 29% 26% 26% 32% 30%
16 9 1 9 7 18 14 15 15 19 20 17 17
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 10 11 11 11 11 11 11 12 12 13 13 13 13
Profit before tax 108 95 75 71 95 108 103 96 142 136 155 168 156
Tax % 31% 24% 17% 9% 25% 25% 21% 13% 29% 26% 25% 25% 26%
Net Profit 75 72 62 64 71 81 81 83 101 101 116 125 115
EPS in Rs 7.26 7.03 6.04 6.24 6.89 7.88 7.92 8.10 9.84 9.85 11.29 12.20 11.23
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
447 554 696 772 631 641 730 1,128 1,029 954 1,616 2,085
352 434 543 580 424 423 531 703 614 601 1,180 1,489
Operating Profit 95 120 153 192 207 218 198 425 415 353 435 595
OPM % 21% 22% 22% 25% 33% 34% 27% 38% 40% 37% 27% 29%
3 4 9 9 6 12 31 30 45 26 61 72
Interest 9 12 18 10 8 3 2 2 2 1 2 1
Depreciation 7 10 15 18 19 22 23 27 33 43 45 52
Profit before tax 82 103 129 174 187 206 203 425 425 335 449 615
Tax % 33% 33% 33% 33% 29% 32% 29% 34% 21% 20% 23% 26%
Net Profit 55 69 86 116 132 140 144 282 334 269 347 458
EPS in Rs 5.56 6.97 8.75 11.22 12.75 13.59 14.00 27.48 32.48 26.20 33.73 44.56
Dividend Payout % 18% 18% 17% 16% 16% 2% 16% 13% 17% 23% 19% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 23%
3 Years: 27%
TTM: 29%
Compounded Profit Growth
10 Years: 21%
5 Years: 26%
3 Years: 11%
TTM: 32%
Stock Price CAGR
10 Years: 42%
5 Years: 29%
3 Years: 23%
1 Year: -11%
Return on Equity
10 Years: 24%
5 Years: 23%
3 Years: 21%
Last Year: 23%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 10 10 10 10 10 10 10 10 10 10 10
Reserves 177 231 300 424 530 670 786 1,041 1,269 1,533 1,818 2,209
173 237 162 65 42 2 15 4 0 2 18 0
45 67 80 100 104 139 168 173 163 188 243 328
Total Liabilities 405 546 552 599 687 821 980 1,228 1,443 1,734 2,090 2,547
144 290 304 327 382 468 457 475 751 757 873 882
CWIP 57 14 10 20 25 7 35 191 31 55 47 221
Investments 8 13 3 3 3 62 132 96 227 289 98 256
196 229 235 249 278 284 356 465 434 633 1,071 1,188
Total Assets 405 546 552 599 687 821 980 1,228 1,443 1,734 2,090 2,547

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
20 92 131 113 167 130 138 200 416 219 127 578
-61 -113 -9 -53 -72 -27 -39 -243 -197 -198 -256 -372
72 22 -113 -75 -50 -45 -30 -40 -109 -3 -46 -86
Net Cash Flow 30 2 9 -16 45 59 70 -83 109 18 -175 121

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 70 75 60 61 66 80 89 79 72 106 104 82
Inventory Days 59 60 41 44 55 79 79 64 79 115 75 64
Days Payable 12 17 12 17 28 40 61 37 47 62 49 40
Cash Conversion Cycle 116 117 89 87 94 119 107 106 104 158 130 107
Working Capital Days 93 77 52 58 62 119 121 112 97 138 141 133
ROCE % 31% 27% 30% 38% 36% 33% 28% 46% 37% 24% 27% 30%

Shareholding Pattern

Numbers in percentages

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
74.06 74.06 74.06 74.06 74.06 74.06 74.06 74.06 74.06 74.06 74.06 74.06
5.08 3.93 3.66 3.50 4.39 4.45 4.53 4.58 4.66 4.76 4.81 4.79
6.17 6.59 6.66 7.29 6.82 6.87 7.54 7.85 8.11 7.99 7.88 7.90
14.69 15.42 15.62 15.15 14.73 14.62 13.87 13.51 13.17 13.19 13.25 13.26

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls